LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults
28 févr. 2024 09h00 HE
|
LiveCare Inc.
Venice, FL, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading innovator in healthcare solutions, proudly announces the launch of a state-of-the-art blood pressure cuff...
Pulmonary Arterial Hypertension Market is estimated to be US$ 12.2 billion by 2032 and is anticipated to register a CAGR of 5.5%. – By PMI
18 oct. 2023 08h30 HE
|
PMI
Covina, Oct. 18, 2023 (GLOBE NEWSWIRE) -- How is PAH diagnosed? Pulmonary Arterial Hypertension (PAH) is the form of broader condition called as pulmonary hypertension, where the...
Global Pulmonary Arterial Hypertension Market Report 2023: Growing Prevalence of Lung Cancer and Other Lung Related Disorders Drives Sector
31 mai 2023 07h23 HE
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market: Analysis By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Region Size and...
Worldwide Pulmonary Arterial Hypertension (PAH) Equipment Industry Report to 2028
04 févr. 2022 06h43 HE
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (PAH) Equipment" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering. ...
Insights on the Pulmonary Arterial Hypertension Global Market to 2027 - Advanced Oral Drugs for Pulmonary Arterial Hypertension Presents Opportunities
26 janv. 2022 06h13 HE
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2021-2027) by Drug Class, Route of Administration, Distribution Mode, and Geography, IGR Competitive Analysis,...
Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth
21 oct. 2021 06h58 HE
|
Research and Markets
Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
Hypertension: 2021 Comprehensive Industry Assessment
01 oct. 2021 09h53 HE
|
Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Hypertension Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Worldwide Pulmonary Arterial Hypertension Industry to 2026 - Advance Oral Drugs for Pulmonary Arterial Hypertension Present Opportunities
05 juil. 2021 04h28 HE
|
Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis...
Global Pulmonary Arterial Hypertension Market Report 2021: Market Leaders Opsumit and Uptravi are Being Investigated in Clinical Trials to Potentially Support Label Expansions to CTEPH
09 juin 2021 08h58 HE
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension Market and Forecast Analysis to 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The report...
Worldwide Pulmonary Arterial Hypertension Industry to 2025 - Featuring Gilead Sciences, United Therapeutics and Novartis International Among Others
20 janv. 2021 06h33 HE
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2020-2025) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis and the...